Tyler E. Miller, MD, PhD
Tyler E. Miller, MD, PhD
Department of Pathology, Massachusetts General Hospital, Boston, MA
Verified email at mgh.harvard.edu
Title
Cited by
Cited by
Year
MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1
TE Miller, K Ghoshal, B Ramaswamy, S Roy, J Datta, CL Shapiro, S Jacob, ...
Journal of biological chemistry 283 (44), 29897-29903, 2008
7862008
Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo
FJ Najm, M Madhavan, A Zaremba, E Shick, RT Karl, DC Factor, TE Miller, ...
Nature 522 (7555), 216-220, 2015
2292015
Brain tumor stem cells: Molecular characteristics and their impact on therapy
DL Schonberg, D Lubelski, TE Miller, JN Rich
Molecular aspects of medicine 39, 82-101, 2014
1442014
Adaptive chromatin remodeling drives glioblastoma stem cell plasticity and drug tolerance
BB Liau, C Sievers, LK Donohue, SM Gillespie, WA Flavahan, TE Miller, ...
Cell stem cell 20 (2), 233-246. e7, 2017
1292017
Preferential iron trafficking characterizes glioblastoma stem-like cells
DL Schonberg, TE Miller, Q Wu, WA Flavahan, NK Das, JS Hale, ...
Cancer cell 28 (4), 441-455, 2015
1222015
Targeting glioma stem cells through combined BMI1 and EZH2 inhibition
X Jin, LJY Kim, Q Wu, LC Wallace, BC Prager, T Sanvoranart, RC Gimple, ...
Nature medicine 23 (11), 1352-1361, 2017
1152017
Anti-microRNA-222 (anti-miR-222) and-181B suppress growth of tamoxifen-resistant xenografts in mouse by targeting TIMP3 protein and modulating mitogenic signal
Y Lu, S Roy, G Nuovo, B Ramaswamy, T Miller, C Shapiro, ST Jacob, ...
Journal of Biological Chemistry 286 (49), 42292-42302, 2011
1002011
Transcription elongation factors represent in vivo cancer dependencies in glioblastoma
TE Miller, BB Liau, LC Wallace, AR Morton, Q Xie, D Dixit, DC Factor, ...
Nature 547 (7663), 355-359, 2017
932017
Myosin II isoform switching mediates invasiveness after TGF-β–induced epithelial–mesenchymal transition
JR Beach, GS Hussey, TE Miller, A Chaudhury, P Patel, J Monslow, ...
Proceedings of the National Academy of Sciences 108 (44), 17991-17996, 2011
902011
Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling
SC Mack, KW Pajtler, L Chavez, K Okonechnikov, KC Bertrand, X Wang, ...
Nature 553 (7686), 101-105, 2018
692018
An epigenetic gateway to brain tumor cell identity
SC Mack, CG Hubert, TE Miller, MD Taylor, JN Rich
Nature neuroscience 19 (1), 10, 2016
642016
Reciprocal signaling between glioblastoma stem cells and differentiated tumor cells promotes malignant progression
X Wang, BC Prager, Q Wu, LJY Kim, RC Gimple, Y Shi, K Yang, ...
Cell Stem Cell 22 (4), 514-528. e5, 2018
572018
N6-methyladenine DNA modification in glioblastoma
Q Xie, TP Wu, RC Gimple, Z Li, BC Prager, Q Wu, Y Yu, P Wang, Y Wang, ...
Cell 175 (5), 1228-1243. e20, 2018
532018
Lineage-specific splicing of a brain-enriched alternative exon promotes glioblastoma progression
R Ferrarese, GR Harsh, AK Yadav, E Bug, D Maticzka, W Reichardt, ...
The Journal of clinical investigation 124 (7), 2861-2876, 2014
532014
Methylation of histone H3 and H4 by PRMT5 regulates ribosomal RNA gene transcription
S Majumder, L Alinari, S Roy, T Miller, J Datta, S Sif, R Baiocchi, ST Jacob
Journal of cellular biochemistry 109 (3), 553-563, 2010
482010
Purine synthesis promotes maintenance of brain tumor initiating cells in glioma
X Wang, K Yang, Q Xie, Q Wu, SC Mack, Y Shi, LJY Kim, BC Prager, ...
Nature neuroscience 20 (5), 661, 2017
422017
MYC-regulated mevalonate metabolism maintains brain tumor–initiating cells
X Wang, Z Huang, Q Wu, BC Prager, SC Mack, K Yang, LJY Kim, ...
Cancer research 77 (18), 4947-4960, 2017
352017
Positively selected enhancer elements endow osteosarcoma cells with metastatic competence
JJ Morrow, I Bayles, APW Funnell, TE Miller, A Saiakhova, MM Lizardo, ...
Nature medicine 24 (2), 176, 2018
292018
Upregulation of glucose-regulated protein 78 in metastatic cancer cells is necessary for lung metastasis progression
MM Lizardo, JJ Morrow, TE Miller, ES Hong, L Ren, A Mendoza, ...
Neoplasia 18 (11), 699-710, 2016
272016
RBPJ maintains brain tumor–initiating cells through CDK9-mediated transcriptional elongation
Q Xie, Q Wu, L Kim, TE Miller, BB Liau, SC Mack, K Yang, DC Factor, ...
The Journal of clinical investigation 126 (7), 2757-2772, 2016
272016
The system can't perform the operation now. Try again later.
Articles 1–20